IP
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IP, covering 2022-04-14 to 2024-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases [Phase 2]